BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni D, Chai Z, Wang Y, Li M, Yu Z, Liu Y, Lu S, Zhang J. Along the allostery stream: Recent advances in computational methods for allosteric drug discovery. WIREs Comput Mol Sci. [DOI: 10.1002/wcms.1585] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Govindaraj RG, Thangapandian S, Schauperl M, Denny RA, Diller DJ. Recent applications of computational methods to allosteric drug discovery. Front Mol Biosci 2022;9:1070328. [PMID: 36710877 DOI: 10.3389/fmolb.2022.1070328] [Reference Citation Analysis]
2 Mousavi H, Zeynizadeh B, Rimaz M. Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3–d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro. Bioorganic Chemistry 2023. [DOI: 10.1016/j.bioorg.2023.106390] [Reference Citation Analysis]
3 Faisal S, Badshah SL, Kubra B, Sharaf M, Emwas A, Jaremko M, Abdalla M. Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches. Molecules 2022;27:5241. [DOI: 10.3390/molecules27165241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Shi Y, Cao S, Ni D, Fan J, Lu S, Xue M. The Role of Conformational Dynamics and Allostery in the Control of Distinct Efficacies of Agonists to the Glucocorticoid Receptor. Front Mol Biosci 2022;9:933676. [DOI: 10.3389/fmolb.2022.933676] [Reference Citation Analysis]
5 Li L, Meyer C, Zhou ZW, Elmezayen A, Westover K. Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families. J Mol Biol 2022;:167626. [PMID: 35595166 DOI: 10.1016/j.jmb.2022.167626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Akimoto M, Martinez Pomier K, VanSchouwen B, Byun JA, Khamina M, Melacini G. Allosteric pluripotency: challenges and opportunities. Biochem J 2022;479:825-38. [PMID: 35403669 DOI: 10.1042/BCJ20210528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 He X, Du K, Wang Y, Fan J, Li M, Ni D, Lu S, Bian X, Liu Y. Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect. Front Mol Biosci 2022;9:860962. [DOI: 10.3389/fmolb.2022.860962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhang H, Zhu M, Li M, Ni D, Wang Y, Deng L, Du K, Lu S, Shi H, Cai C. Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1. Front Pharmacol 2022;13:862504. [DOI: 10.3389/fphar.2022.862504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Ni D, Liu Y, Kong R, Yu Z, Lu S, Zhang J. Computational elucidation of allosteric communication in proteins for allosteric drug design. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fan J, Liu Y, Kong R, Ni D, Yu Z, Lu S, Zhang J. Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery. J Med Chem 2021;64:17728-43. [PMID: 34878270 DOI: 10.1021/acs.jmedchem.1c01695] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]